BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: N-acylsphingosine amidohydrolase 1 (ASAH1)

August 13, 2015 7:00 AM UTC

Mouse studies suggest activating ASAH1 could help treat hepatic steatosis. In mouse models of diet-induced obesity, liver-specific overexpression of ASAH1 increased glucose tolerance and insulin sensi...